Compare $ORGS vs $VCNX | Chartloom

Compare

$ORGS vs $VCNX

Orgenesis Inc · Vaccinex Inc

ORGS

Orgenesis Inc

VCNX

Vaccinex Inc

Compare $ORGS vs $VCNX

Comparing Orgenesis Inc and Vaccinex Inc

ORGSOrgenesis Inc

VCNXVaccinex Inc

ORGSOrgenesis Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-92.8%

YTD performance

133.3%

52W performance

-56.3%

FCF yield

-505.5%

VCNXVaccinex Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

5.4%

YTD performance

0.9%

52W performance

29.8%

FCF yield

-530.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ORGS

VCNX

Detailed metrics comparison

ORGS

Orgenesis Inc

VCNX

Vaccinex Inc

Market Cap

ORGS$3M

VCNX$3M

Enterprise Value

ORGS$20M

VCNX$2M

Price

ORGS$0.35

VCNX$1.14

P/E Ratio

ORGSN/A

VCNXN/A

P/S Ratio

ORGS3.31x

VCNX5.08x

EV/Sales

ORGS19.39x

VCNX3.28x

EV/EBITDA

ORGS0.00x

VCNX0.00x

P/B Ratio

ORGS0.28x

VCNX1.15x

P/FCF Ratio

ORGSN/A

VCNXN/A

EV/FCF

ORGS-1.16x

VCNX-0.12x

PEG Ratio

ORGSN/A

VCNXN/A

Forward P/E (NTM)

ORGSN/A

VCNXN/A

Forward P/S (NTM)

ORGSN/A

VCNXN/A

Revenue (TTM)

ORGS$1M

VCNX$601K

Revenue Growth (YoY)

ORGS-92.8%

VCNX5.4%

Forward Rev Growth

ORGS0.0%

VCNX0.0%

Gross Margin (TTM)

ORGS-86.3%

VCNX99.7%

Operating Margin (TTM)

ORGS0.0%

VCNX0.0%

EBITDA Margin (TTM)

ORGS-1868.2%

VCNX-3101.7%

Net Margin (TTM)

ORGS-4653.6%

VCNX-3100.5%

FCF Margin (TTM)

ORGS-1675.3%

VCNX-2696.8%

Net Income (TTM)

ORGS$-48M

VCNX$-19M

FCF (TTM)

ORGS$-17M

VCNX$-16M

EPS (TTM)

ORGS-$9.58

VCNX-$5.78

ROE (TTM)

ORGS-10936.0%

VCNX-14678.0%

ROA (TTM)

ORGS-20820.0%

VCNX-43375.0%

ROIC (TTM)

ORGS-5864.0%

VCNX-14238.0%

Cash

ORGS$78K

VCNX$1M

Debt

ORGS$17M

VCNX$25K

Net Cash/Debt

ORGS$-17M

VCNX$1M

Current Ratio (TTM)

ORGS0.03x

VCNX0.50x

Quick Ratio (TTM)

ORGS0.03x

VCNX0.38x

Debt/Equity (TTM)

ORGS1.73x

VCNX0.03x

Debt/Assets (TTM)

ORGS0.0%

VCNX0.0%

Interest Coverage (TTM)

ORGSN/A

VCNXN/A

Net Debt/EBITDA (TTM)

ORGS0.00x

VCNX0.00x

Beta

ORGS3.73

VCNX0.73

52W Performance

ORGS-56.3%

VCNX29.8%

YTD Performance

ORGS133.3%

VCNX0.9%

% from 52W High

ORGS-65.0%

VCNX-24.0%

% from 52W Low

ORGS34900.0%

VCNX267.7%

Asset Turnover (TTM)

ORGS0.04x

VCNX0.14x

FCF Yield (TTM)

ORGS-505.5%

VCNX-530.5%

Earnings Yield (TTM)

ORGS-1404.2%

VCNX-609.9%

Dividend Yield (TTM)

ORGSN/A

VCNXN/A

Rule of 40

ORGS-1,768.0

VCNX-2,691.4

EV/GP/RG

ORGSN/A

VCNXN/A

Ticker research

View ORGS research View VCNX research

Metric	ORGS Orgenesis Inc	VCNX Vaccinex Inc
Market & Valuation
Market Cap	$3M	$3M
Enterprise Value	$20M	$2M
Price	$0.35	$1.14
P/E Ratio	N/A	N/A
P/S Ratio	3.31x	5.08x
EV/Sales	19.39x	3.28x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.28x	1.15x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.16x	-0.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$1M	$601K
Revenue Growth (YoY)	-92.8%	5.4%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	-86.3%	99.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1868.2%	-3101.7%
Net Margin (TTM)	-4653.6%	-3100.5%
FCF Margin (TTM)	-1675.3%	-2696.8%
Net Income (TTM)	$-48M	$-19M
FCF (TTM)	$-17M	$-16M
EPS (TTM)	-$9.58	-$5.78
ROE (TTM)	-10936.0%	-14678.0%
ROA (TTM)	-20820.0%	-43375.0%
ROIC (TTM)	-5864.0%	-14238.0%
Financial Health
Cash	$78K	$1M
Debt	$17M	$25K
Net Cash/Debt	$-17M	$1M
Current Ratio (TTM)	0.03x	0.50x
Quick Ratio (TTM)	0.03x	0.38x
Debt/Equity (TTM)	1.73x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.73	0.73
52W Performance	-56.3%	29.8%
YTD Performance	133.3%	0.9%
% from 52W High	-65.0%	-24.0%
% from 52W Low	34900.0%	267.7%
Efficiency & Yields
Asset Turnover (TTM)	0.04x	0.14x
FCF Yield (TTM)	-505.5%	-530.5%
Earnings Yield (TTM)	-1404.2%	-609.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,768.0	-2,691.4
EV/GP/RG	N/A	N/A
Ticker research	View ORGS research	View VCNX research

Valuation

P/S Ratio

ORGS

3.31x

VCNX

5.08x

EV/FCF

ORGS

-1.16x

VCNX

-0.12x

Growth & revenue

Revenue Growth TTM

VCNX

5.4%

ORGS

-92.8%

Forward Revenue Growth

ORGS

0.0%

VCNX

0.0%

Profitability & performance

Gross Margin

VCNX

99.7%

ORGS

-86.3%

ROE

ORGS

-10936.0%

VCNX

-14678.0%

FCF Yield %

ORGS

-505.5%

VCNX

-530.5%

52-Week Performance

VCNX

29.8%

ORGS

-56.3%

Detailed metrics comparison

ORGS

Orgenesis Inc

VCNX

Vaccinex Inc

Market Cap

ORGS$3M

VCNX$3M

Enterprise Value

ORGS$20M

VCNX$2M

Price

ORGS$0.35

VCNX$1.14

P/E Ratio

ORGSN/A

VCNXN/A

P/S Ratio

ORGS3.31x

VCNX5.08x

EV/Sales

ORGS19.39x

VCNX3.28x

EV/EBITDA

ORGS0.00x

VCNX0.00x

P/B Ratio

ORGS0.28x

VCNX1.15x

P/FCF Ratio

ORGSN/A

VCNXN/A

EV/FCF

ORGS-1.16x

VCNX-0.12x

PEG Ratio

ORGSN/A

VCNXN/A

Forward P/E (NTM)

ORGSN/A

VCNXN/A

Forward P/S (NTM)

ORGSN/A

VCNXN/A

Revenue (TTM)

ORGS$1M

VCNX$601K

Revenue Growth (YoY)

ORGS-92.8%

VCNX5.4%

Forward Rev Growth

ORGS0.0%

VCNX0.0%

Gross Margin (TTM)

ORGS-86.3%

VCNX99.7%

Operating Margin (TTM)

ORGS0.0%

VCNX0.0%

EBITDA Margin (TTM)

ORGS-1868.2%

VCNX-3101.7%

Net Margin (TTM)

ORGS-4653.6%

VCNX-3100.5%

FCF Margin (TTM)

ORGS-1675.3%

VCNX-2696.8%

Net Income (TTM)

ORGS$-48M

VCNX$-19M

FCF (TTM)

ORGS$-17M

VCNX$-16M

EPS (TTM)

ORGS-$9.58

VCNX-$5.78

ROE (TTM)

ORGS-10936.0%

VCNX-14678.0%

ROA (TTM)

ORGS-20820.0%

VCNX-43375.0%

ROIC (TTM)

ORGS-5864.0%

VCNX-14238.0%

Cash

ORGS$78K

VCNX$1M

Debt

ORGS$17M

VCNX$25K

Net Cash/Debt

ORGS$-17M

VCNX$1M

Current Ratio (TTM)

ORGS0.03x

VCNX0.50x

Quick Ratio (TTM)

ORGS0.03x

VCNX0.38x

Debt/Equity (TTM)

ORGS1.73x

VCNX0.03x

Debt/Assets (TTM)

ORGS0.0%

VCNX0.0%

Interest Coverage (TTM)

ORGSN/A

VCNXN/A

Net Debt/EBITDA (TTM)

ORGS0.00x

VCNX0.00x

Beta

ORGS3.73

VCNX0.73

52W Performance

ORGS-56.3%

VCNX29.8%

YTD Performance

ORGS133.3%

VCNX0.9%

% from 52W High

ORGS-65.0%

VCNX-24.0%

% from 52W Low

ORGS34900.0%

VCNX267.7%

Asset Turnover (TTM)

ORGS0.04x

VCNX0.14x

FCF Yield (TTM)

ORGS-505.5%

VCNX-530.5%

Earnings Yield (TTM)

ORGS-1404.2%

VCNX-609.9%

Dividend Yield (TTM)

ORGSN/A

VCNXN/A

Rule of 40

ORGS-1,768.0

VCNX-2,691.4

EV/GP/RG

ORGSN/A

VCNXN/A

Ticker research

View ORGS research View VCNX research

Metric	ORGS Orgenesis Inc	VCNX Vaccinex Inc
Market & Valuation
Market Cap	$3M	$3M
Enterprise Value	$20M	$2M
Price	$0.35	$1.14
P/E Ratio	N/A	N/A
P/S Ratio	3.31x	5.08x
EV/Sales	19.39x	3.28x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.28x	1.15x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.16x	-0.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$1M	$601K
Revenue Growth (YoY)	-92.8%	5.4%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	-86.3%	99.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1868.2%	-3101.7%
Net Margin (TTM)	-4653.6%	-3100.5%
FCF Margin (TTM)	-1675.3%	-2696.8%
Net Income (TTM)	$-48M	$-19M
FCF (TTM)	$-17M	$-16M
EPS (TTM)	-$9.58	-$5.78
ROE (TTM)	-10936.0%	-14678.0%
ROA (TTM)	-20820.0%	-43375.0%
ROIC (TTM)	-5864.0%	-14238.0%
Financial Health
Cash	$78K	$1M
Debt	$17M	$25K
Net Cash/Debt	$-17M	$1M
Current Ratio (TTM)	0.03x	0.50x
Quick Ratio (TTM)	0.03x	0.38x
Debt/Equity (TTM)	1.73x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.73	0.73
52W Performance	-56.3%	29.8%
YTD Performance	133.3%	0.9%
% from 52W High	-65.0%	-24.0%
% from 52W Low	34900.0%	267.7%
Efficiency & Yields
Asset Turnover (TTM)	0.04x	0.14x
FCF Yield (TTM)	-505.5%	-530.5%
Earnings Yield (TTM)	-1404.2%	-609.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,768.0	-2,691.4
EV/GP/RG	N/A	N/A
Ticker research	View ORGS research	View VCNX research